Thu.Aug 04, 2022

Why should you explain WHY?


Remember the five “W’s?”. In my early journalism classes, I was taught the five “W’s” of good news stories, and that most should be in the first paragraph at that. Who, what, when, where and why are the five, with sometimes a “how” thrown in for those followers of the macabre.

Based Takes $3.5M For NFT Effort


Based, which says it is developing a "communications platform built around NFTs", said from Los Angeles today that it raised $3.5M in a pre-seed funding. The company said the funding wass led by Progression Fund, and also included Hannah Grey, Collab+Currency, Palm Tree Crew, Franklin Templeton, GFR, and crypto-focused angels and influencers. The company said it enables users to "easily surface NFT content from their friends and communities". based venture capital crypto


Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

The Bounty App Picks Up $5M


A new, Los Angeles-based startup, Bounty, developing tools to help creators earn money on TikTok, says it has raised $5M in its seed funding round. The funding was led by M13, and also included Sugar Capital and Interlace Ventures, along with angels. According to the company, it has now raised $6.777M in total. The company said the new funds will go towards meeting demand and product development, as well as hiring plans for its engineering, design, and marketing departments.

Venture MLS Invests In SavvyCard


Chino Hills-based Venture MLS, a real estate focused venture capital firm which was founded by a multiple listing service (MLS), said it has made an investment in SavvyCard, which provides software for real estate marketing, lead generation, and targeted advertising. Financial details of the investment were not announced.

Invest 109

Can You Ask for Office Rent Relief? How to Manage Your Lease During COVID-19

Office leases are one of companies’ largest expenses, and if your whole team is working from home with no clear end in sight, you may be wondering what to do about your lease.

Amgen Buys Chemocentryx For $4 Billion In Cash


Thousand Oaks-based biotech giant Amgen says it is acquiring ChemoCentryx, a publicly traded biopharmaceuticals company which is focused on orally administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. The company said it will pay $52 per share in cash for ChemoCentryx, with an enterprise value of approximately $3.7 billion. Amgen was advised by PJT Partners, with legal advice from Wachtell, Lipton, Rosen & Katz.